M S CRESCENT PHARMA LIMITED — Ramipril Importer Profile
Pharmaceutical Importer · #16 buyer for Ramipril · $1.4M import value · 67 shipments · UNITED KINGDOM · DGFT Verified
M S CRESCENT PHARMA LIMITED is the #16 importer of Ramipril from India with $1.4M in import value and 67 verified shipments. M S CRESCENT PHARMA LIMITED holds a 1.3% market share in Ramipril imports based in UNITED KINGDOM. The company sources from 1 verified supplier across 15 formulations shipped to 1 country.
M S CRESCENT PHARMA LIMITED — Ramipril Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ramipril to M S CRESCENT PHARMA LIMITED?
Verified from 67 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GENO PHARMACEUTICALS PRIVATE LIMITED | $1.4M | 67 | 100.0% |
M S CRESCENT PHARMA LIMITED sources Ramipril from 1 verified Indian supplier based on 67 customs records. The primary supplier is GENO PHARMACEUTICALS PRIVATE LIMITED accounting for 100.0% of imports.
How Does M S CRESCENT PHARMA LIMITED Compare to Nearest Ramipril Importers?
Buyers ranked immediately above and below #16 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 14 | AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $1.5M | 46 | $31.8K |
| 15 | APL SWIFT SERVICES (MALTA) LTD., | MALTA | $1.2M | 257 | $4.5K |
| 16 | M S CRESCENT PHARMA LIMITED ★ | UNITED KINGDOM | $1.1M | 45 | $25.3K |
| 9 | SANOFI SAGLIK URUNLERI LTD STI | TURKEY | $1.1M | 22 | $50.0K |
M S CRESCENT PHARMA LIMITED ranks #16 among 389 Ramipril importers from India. Average shipment value of $25.3K compared to the market average of $102.1K. The closest competitors by value are AUROLOGISTICS LLC, (AUROBINDO PHARM and APL SWIFT SERVICES (MALTA) LTD.,.
Where Does M S CRESCENT PHARMA LIMITED Import Ramipril To?
Destination countries from 67 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $1.4M | 67 | 100.0% |
M S CRESCENT PHARMA LIMITED imports Ramipril to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $1.4M.
What Ramipril Formulations Does M S CRESCENT PHARMA LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| RAMIPRIL CAPSULES 10MG 2X14'S | $496.9K | 13 |
| RAMIPRIL CAPSULES 5MG 2X14'S | $421.8K | 11 |
| RAMIPRIL CAPSULES 2.5MG 2X14'S | $409.4K | 13 |
| RAMIPRIL CAPSULES 10MG 2X14'S4228000 CAPSULES | $50.0K | 1 |
| RAMIPRIL CAPSULES 10MG 2X14'S4312000 CAPSULES | $50.0K | 1 |
| TESTING SAMPLES OF RAMIPRIL CAPSULES 5MG2X14?S | $120 | 7 |
| TESTING SAMPLES OF RAMIPRIL CAPSULES 10MG 2X14?S | $109 | 6 |
| TESTING SAMPLES OF RAMIPRIL CAPSULES 2.5MG 2X14?S | $96 | 8 |
| TESTING SAMPLES OF RAMIPRIL CAPSULES 10MG 2X14?S1680 CAPSULES | $24 | 1 |
| TESTING SAMPLES OF RAMIPRIL CAPSULES 2.5MG 2X14'S | $12 | 1 |
M S CRESCENT PHARMA LIMITED imports 15 distinct Ramipril formulations from India. The top formulation is RAMIPRIL CAPSULES 10MG 2X14'S with 13 shipments worth $496.9K.
Regulatory Requirements: Importing Ramipril into United Kingdom
What M S CRESCENT PHARMA LIMITED and other importers must comply with to import Ramipril from India
Regulatory Authority
Medicines and Healthcare products Regulatory Agency (MHRA)
Approval Process for Generic Ramipril
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
GMP Requirements
UK GMP compliance; MHRA GMP inspection of manufacturing site
Import Licence & Documentation
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
Labeling & Packaging
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Ramipril from India and How Much Does M S CRESCENT PHARMA LIMITED Import?
India exported $39.7M worth of Ramipril through 4,977 shipments from 177 suppliers to 93 countries, serving 389 buyers globally. M S CRESCENT PHARMA LIMITED imports $1.4M of this total, accounting for 1.3% of India's Ramipril exports with 67 shipments from UNITED KINGDOM. This is verified from 67 customs shipment records covering 15 distinct formulations.
What Is the Average Order Value for M S CRESCENT PHARMA LIMITED's Ramipril Imports?
M S CRESCENT PHARMA LIMITED's average Ramipril order value is $21.3K per consignment, based on 67 shipments totaling $1.4M. M S CRESCENT PHARMA LIMITED is based in UNITED KINGDOM and ranks #16 among all Ramipril importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Ramipril to M S CRESCENT PHARMA LIMITED?
M S CRESCENT PHARMA LIMITED sources Ramipril from 1 verified Indian supplier: GENO PHARMACEUTICALS PRIVATE LIMITED ($1.4M, 100.0%). This is based on 67 customs records.
How Does M S CRESCENT PHARMA LIMITED Compare to Other Ramipril Importers?
M S CRESCENT PHARMA LIMITED ranks #16 among 389 Ramipril importers from India with a 1.3% market share. The top 3 importers are WOCKHARDT UK LIMITED ($6.7M), CRESCENT PHARMA LTD ($5.8M), BROWN AND BURK UK LIMITED ($4.0M). M S CRESCENT PHARMA LIMITED processed 67 shipments from UNITED KINGDOM.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ramipril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ramipril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: M S CRESCENT PHARMA LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as M S CRESCENT PHARMA LIMITED's capped import value divided by total capped export value for Ramipril across all Indian exporters.
- 5.Verified Records: This page is backed by 67 individual customs records matching M S CRESCENT PHARMA LIMITED importing Ramipril, covering 15 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 93+ countries, 389+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ramipril Import Data for M S CRESCENT PHARMA LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for M S CRESCENT PHARMA LIMITED's Ramipril imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
M S CRESCENT PHARMA LIMITED
Company Profile
Multiple products · $0 total trade · Multiple categories
M S CRESCENT PHARMA LIMITED × Ramipril
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for M S CRESCENT PHARMA LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ramipril. For current order-level data, contact TransData Nexus.